ID

37589

Descripción

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function; ODM derived from: https://clinicaltrials.gov/show/NCT01896297

Link

https://clinicaltrials.gov/show/NCT01896297

Palabras clave

Versiones (1)
  1. 8/8/19 8/8/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

8 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Atrial Fibrillation NCT01896297

Inglés

Eligibility Atrial Fibrillation NCT01896297

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects diagnosed with non-valvular atrial fibrillation with an indication for the anticoagulation therapy,
Descripción

Atrial Fibrillation | Indication Anticoagulation Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C0003281
subjects with severe renal function impairment defined as creatinine clearance between 15 and 30 ml/min by cockcroft-gault formula,
Descripción

Renal Insufficiency Severe | Estimation of creatinine clearance by Cockcroft-Gault formula

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C2711451
male and female patients, age =18 years at entry
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications to pradaxa (history of a serious hypersensitivity reaction to pradaxa, active pathological bleeding, patients with mechanical prosthetic heart valve),
Descripción

Medical contraindication Pradaxa | Hypersensitivity Serious Pradaxa | Hemorrhage | Mechanical heart valve prosthesis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C2940579
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C2940579
UMLS CUI [3]
C0019080
UMLS CUI [4]
C3873910
creatinine clearance <15ml/min or patients with end stage renal disease on dialysis,
Descripción

Creatinine clearance measurement | Kidney Failure, Chronic | Dialysis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
UMLS CUI [2]
C0022661
UMLS CUI [3]
C0011946
creatinine clearance >30 ml/min,
Descripción

Creatinine clearance measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
pre-menopausal women (last menstruation less than one year prior to informed consent) who are nursing or pregnant, or are of child bearing potential and are not practicing an acceptable method of birth control, or do not plan to continue using this method throughout the study. acceptable methods of birth control include abstinence, tubal ligation, transdermal patch, intra uterine devices/systems (iuds/iuss), oral, implantable or injectable contraceptives, double barrier method and vasectomised partner,
Descripción

Premenopausal state | Breast Feeding | Pregnancy | Childbearing Potential Contraceptive methods Absent | Sexual Abstinence | Tubal Ligation | Transdermal patch as birth control method | Intrauterine Devices | Contraceptives, Oral | Contraceptive implant | Contraceptive injection | Barrier Contraception Double | Partner had vasectomy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032961
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0700589
UMLS CUI [4,3]
C0332197
UMLS CUI [5]
C0036899
UMLS CUI [6]
C0520483
UMLS CUI [7]
C2135981
UMLS CUI [8]
C0021900
UMLS CUI [9]
C0009905
UMLS CUI [10]
C1657106
UMLS CUI [11]
C1656586
UMLS CUI [12,1]
C0004764
UMLS CUI [12,2]
C0205173
UMLS CUI [13]
C0420842
patients who are participating in another drug study,
Descripción

Study Subject Participation Status | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
patients who have participated in another drug study within 6 weeks,
Descripción

Study Subject Participation Status Previous | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0205156
UMLS CUI [2]
C0013230
patients considered unreliable by the investigator concerning the requirements for participating in the study, including a follow-up interview,
Descripción

Study Subject Participation Status | Protocol Compliance Unlikely

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0750558
any condition the investigator believes would not allow safe participation in the study,
Descripción

Condition Study Subject Participation Status At risk

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1444641
Volver a la parte superior de la página

Similar models

Eligibility Atrial Fibrillation NCT01896297

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Atrial Fibrillation | Indication Anticoagulation Therapy
Item
subjects diagnosed with non-valvular atrial fibrillation with an indication for the anticoagulation therapy,
boolean
C0004238 (UMLS CUI [1])
C3146298 (UMLS CUI [2,1])
C0003281 (UMLS CUI [2,2])
Renal Insufficiency Severe | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
subjects with severe renal function impairment defined as creatinine clearance between 15 and 30 ml/min by cockcroft-gault formula,
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2711451 (UMLS CUI [2])
Age
Item
male and female patients, age =18 years at entry
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Pradaxa | Hypersensitivity Serious Pradaxa | Hemorrhage | Mechanical heart valve prosthesis
Item
contraindications to pradaxa (history of a serious hypersensitivity reaction to pradaxa, active pathological bleeding, patients with mechanical prosthetic heart valve),
boolean
C1301624 (UMLS CUI [1,1])
C2940579 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C2940579 (UMLS CUI [2,3])
C0019080 (UMLS CUI [3])
C3873910 (UMLS CUI [4])
Creatinine clearance measurement | Kidney Failure, Chronic | Dialysis
Item
creatinine clearance <15ml/min or patients with end stage renal disease on dialysis,
boolean
C0373595 (UMLS CUI [1])
C0022661 (UMLS CUI [2])
C0011946 (UMLS CUI [3])
Creatinine clearance measurement
Item
creatinine clearance >30 ml/min,
boolean
C0373595 (UMLS CUI [1])
Premenopausal state | Breast Feeding | Pregnancy | Childbearing Potential Contraceptive methods Absent | Sexual Abstinence | Tubal Ligation | Transdermal patch as birth control method | Intrauterine Devices | Contraceptives, Oral | Contraceptive implant | Contraceptive injection | Barrier Contraception Double | Partner had vasectomy
Item
pre-menopausal women (last menstruation less than one year prior to informed consent) who are nursing or pregnant, or are of child bearing potential and are not practicing an acceptable method of birth control, or do not plan to continue using this method throughout the study. acceptable methods of birth control include abstinence, tubal ligation, transdermal patch, intra uterine devices/systems (iuds/iuss), oral, implantable or injectable contraceptives, double barrier method and vasectomised partner,
boolean
C0232969 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C0036899 (UMLS CUI [5])
C0520483 (UMLS CUI [6])
C2135981 (UMLS CUI [7])
C0021900 (UMLS CUI [8])
C0009905 (UMLS CUI [9])
C1657106 (UMLS CUI [10])
C1656586 (UMLS CUI [11])
C0004764 (UMLS CUI [12,1])
C0205173 (UMLS CUI [12,2])
C0420842 (UMLS CUI [13])
Study Subject Participation Status | Investigational New Drugs
Item
patients who are participating in another drug study,
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Study Subject Participation Status Previous | Investigational New Drugs
Item
patients who have participated in another drug study within 6 weeks,
boolean
C2348568 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
Study Subject Participation Status | Protocol Compliance Unlikely
Item
patients considered unreliable by the investigator concerning the requirements for participating in the study, including a follow-up interview,
boolean
C2348568 (UMLS CUI [1])
C0525058 (UMLS CUI [2,1])
C0750558 (UMLS CUI [2,2])
Condition Study Subject Participation Status At risk
Item
any condition the investigator believes would not allow safe participation in the study,
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial